We found that in B cell subpopulation both CLL patients and healthy donors did not differ significantly when comparing the median proportions of BTLA positive and negative IL-4 secreting cells (Table 2, Figure S2 in Supplementary Materials). This evidence concerns the gene IL4 and B-cell chronic lymphocytic leukemia.